Synergy Pharmaceuticals Inc (NASDAQ:SGYP)

1.78
Delayed Data
As of 11:58am ET
 0.00 / 0.00%
Today’s Change
1.68
Today|||52-Week Range
4.84
-20.18%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$535.3M

Company Description

Synergy Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on the development and commercialization of novel gastrointestinal therapies. Its product includes plecanatide and dolcanatide. The company was founded by Kunwar Shailubhai on November 15, 2005 and is headquartered in New York, NY.

Contact Information

Synergy Pharmaceuticals, Inc.
420 Lexington Avenue
New York New York 10170
P:(212) 297-0020
Investor Relations:
(212) 584-7610

Employees

Shareholders

Individual stakeholders6.89%
Other institutional28.31%
Mutual fund holders25.30%

Top Executives

Troy HamiltonChief Executive Officer & Director
Gary G. GemignaniChief Financial Officer & Executive Vice President
Patrick H. GriffinChief Medical Officer & Executive Vice President
Leslie M. MagnusSenior Vice President-Medical Affairs
Chhaya ShahSenior VP-Manufacturing & Technical Operations